Epigenetic reprogramming during the maternal‐to‐zygotic transition

Yurong Chen, Luyao Wang, Fucheng Guo, Xiangpeng Dai, Xiaoling ZhangMedComm 2023 · DOI

TL;DR

This review dives into the intricate process of epigenetic reprogramming during the maternal-to-zygotic transition (MZT) in mammalian embryos. It highlights how dynamic changes in DNA methylation, histone modifications, and 3D chromatin structure are crucial for the successful transition from maternal control to embryonic genome activation, and how disruptions can lead to developmental failure.

What Problem Does This Paper Address?

The journey from a fertilized egg to a developing embryo is a marvel of biological precision, and a critical early step is the maternal-to-zygotic transition (MZT). During MZT, the embryo must shed its maternal legacy (degrading maternal RNAs and proteins) and activate its own genome. This complex transition is orchestrated by a massive overhaul of the epigenome – the layer of chemical modifications that control gene expression without altering the underlying DNA sequence. While the importance of MZT and epigenetics is recognized, the precise molecular mechanisms and the intricate interplay of various epigenetic modifications during this period, especially in mammals, have remained somewhat enigmatic. This paper aims to consolidate and discuss the latest findings on how epigenetic reprogramming guides MZT, offering a comprehensive overview for understanding this fundamental developmental process and its implications for reproductive health.

Methods

This paper is a review, synthesizing existing research rather than presenting new experimental data. The authors draw upon a wide range of studies that have employed advanced techniques for analyzing epigenetic modifications in early embryos. These include:

  • Low-input epigenome profiling technologies: Techniques like ChIP-seq (Chromatin Immunoprecipitation sequencing) and CUT&RUN (Cleavage Under Targets and Release Using Nuclease) are highlighted for their ability to profile histone modifications and DNA-binding proteins from limited embryonic material.
  • Single-cell multi-omics sequencing: This approach allows for the analysis of multiple layers of molecular information (e.g., epigenetics, transcriptomics) at the single-cell level, providing a more detailed view of dynamic changes during early development.
  • Advanced imaging and molecular biology techniques: Immunofluorescence staining, CRISPR/Cas9-mediated gene editing, and various biochemical assays are frequently used in the cited studies to investigate the roles of specific epigenetic regulators and modifications.

Datasets

Not discussed in the paper. As a review, it synthesizes data from numerous published studies.

Key Insights and Ideas

  • MZT is an epigenetic symphony: The transition from maternal to zygotic control isn't just about turning genes on or off; it's a carefully choreographed epigenetic reprogramming event involving widespread changes in DNA methylation, histone marks, and 3D chromatin structure.
  • Dynamic histone modifications are key players: Histones, the proteins DNA wraps around, undergo dramatic changes. For instance, H3K4me3, typically associated with active genes, appears in unusual "noncanonical" patterns in oocytes and early embryos, only to be replaced by canonical patterns as the zygotic genome activates. Similarly, H3K27me3 and H2AK119ub1, marks of gene silencing, are also dynamically regulated.
  • DNA demethylation is a major event: Gametes are heavily methylated. After fertilization, a global wave of DNA demethylation occurs, with distinct patterns and timing for maternal and paternal genomes, crucial for resetting the developmental program.
  • 3D chromatin structure is re-established: The spatial organization of DNA within the nucleus, including compartments (A/B) and topologically associating domains (TADs), is largely dismantled after fertilization and then gradually rebuilt, influencing gene accessibility.
  • RNA modifications are emerging players: N6-methyladenosine (m6A), a modification on RNA, is increasingly recognized for its role in maternal mRNA decay and zygotic genome activation.
  • Interplay is crucial: Different epigenetic modifications don't act in isolation. They interact and influence each other, creating a complex regulatory network that must be precisely tuned for successful development.
  • Dysregulation leads to failure: Errors in this epigenetic reprogramming process are linked to developmental defects and can contribute to embryonic failure, highlighting its critical importance for reproductive success.

Key Results

As a review, this paper doesn't present new quantitative results. Instead, it synthesizes findings from numerous studies, highlighting:

  • Conservation across mammals: Many epigenetic reprogramming events during MZT, such as global DNA demethylation and dynamic histone modification changes, are conserved between mice and humans, though species-specific differences exist.
  • Timing is critical: The precise timing of these epigenetic events is crucial. For example, the removal of noncanonical H3K4me3 is linked to zygotic genome activation (ZGA), and the establishment of canonical H3K4me3 occurs around the time of major ZGA.
  • Role of specific factors: The review details the roles of various enzymes and proteins (e.g., TET3, DNMT1, KMT2B, PRC2, CTCF) in mediating these epigenetic changes.

Limitations and Future Work

The authors acknowledge that despite significant progress, many aspects of epigenetic reprogramming during MZT remain enigmatic. Key areas for future research include:

  • Precise molecular mechanisms: While many epigenetic modifications and their regulators have been identified, the detailed molecular mechanisms by which they interact and orchestrate MZT are still largely unknown.
  • Interplay of modifications: The complex crosstalk between different epigenetic marks (e.g., DNA methylation, histone modifications, 3D chromatin structure) needs further elucidation.
  • Role of non-coding RNAs: The precise roles of non-coding RNAs in regulating epigenetic reprogramming during MZT warrant deeper investigation.
  • Human embryo studies: While mouse models have provided significant insights, more research on human embryos is needed to fully understand species-specific nuances.
  • Clinical implications: Further understanding of these processes could lead to novel strategies for treating infertility and improving outcomes in assisted reproductive technologies.

Summary updated

Abstract

After fertilization, sperm and oocyte fused and gave rise to a zygote which is the beginning of a new life. Then the embryonic development is monitored and regulated precisely from the transition of oocyte to the embryo at the early stage of embryogenesis, and this process is termed maternal-to-zygotic transition (MZT). MZT involves two major events that are maternal components degradation and zygotic genome activation. The epigenetic reprogramming plays crucial roles in regulating the process of MZT and supervising the normal development of early development of embryos. In recent years, benefited from the rapid development of low-input epigenome profiling technologies, new epigenetic modifications are found to be reprogrammed dramatically and may play different roles during MZT whose dysregulation will cause an abnormal development of embryos even abortion at various stages. In this review, we summarized and discussed the important novel findings on epigenetic reprogramming and the underlying molecular mechanisms regulating MZT in mammalian embryos. Our work provided comprehensive and detailed references for the in deep understanding of epigenetic regulatory network in this key biological process and also shed light on the critical roles for epigenetic reprogramming on embryonic failure during artificial reproductive technology and nature fertilization.
BibTeX
@inproceedings{chen2023epigenetic,
  author = {Yurong Chen and Luyao Wang and Fucheng Guo and Xiangpeng Dai and Xiaoling Zhang},
  title = {{Epigenetic reprogramming during the maternal‐to‐zygotic transition}},
  booktitle = {MedComm},
  year = {2023},
  doi = {10.1002/mco2.331},
}
Figure